irinotecan koanaa 20mg/ml, concentrate for solution for infusion (5ml vial)
koanaa healthcare limited - irinotecan hydrochloride, trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 100 milligram(s)/5 millilitre - antineoplastic agents
irinotecan koanaa 20mg/ml, concentrate for solution for infusion (15ml vial)
koanaa healthcare limited - irinotecan hydrochloride, trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 300/15 milligram(s)/millilitre - antineoplastic agents
irinotecan koanaa 20mg/ml concentrate for solution for infusion (25ml vial)
koanaa healthcare limited - irinotecan hydrochloride, trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 milligram(s)/millilitre - antineoplastic agents
irinotecan 20 mg/ml concentrate for solution for infusion
fresenius kabi deutschland gmbh - irinotecan - concentrate for solution for infusion - 20 milligram(s)/millilitre - other antineoplastic agents; miltefosine
irinotecan hydrochloride 20 mg/ml concentrate for solution for infusion
accord healthcare ireland ltd. - irinotecan hydrochloride trihydrate - concentrate for solution for infusion - 20 milligram(s)/millilitre - other antineoplastic agents; irinotecan
arzerra 100mg5ml concentrate for solution for infusion vials
novartis pharmaceuticals uk ltd - ofatumumab - solution for infusion - 20mg/1ml
arzerra 1000mg50ml concentrate for solution for infusion vials
novartis pharmaceuticals uk ltd - ofatumumab - solution for infusion - 20mg/1ml
portrazza 800mg50ml concentrate for solution for infusion vials
eli lilly and company ltd - necitumumab - solution for infusion - 16mg/1ml
ocrevus 300mg10ml concentrate for solution for infusion vials
roche products ltd - ocrelizumab - solution for infusion - 30mg/1ml
mabthera 100mg10ml concentrate for solution for infusion vials
roche products ltd - rituximab - solution for infusion - 10mg/1ml